Roche Acquires GeneWEAVE for $190M Upfront, Up to $235M in Contingent Product-Related Milestones
August 13, 2015 at 04:43 AM EDT
Roche (OTC: RHHBY) today announced that it has signed a definitive agreement to acquire GeneWEAVE BioSciences, Inc. (GeneWEAVE), a ...
